TECFIDERA is used to treat relapsing multiple sclerosis (MS).
TECFIDERA slows down the progression of physical disability in people with relapsing
forms of MS and decreases the number of flare ups (relapses).
Some people feel better when they start to take TECFIDERA. However TECFIDERA cannot
repair damage that has already been caused by MS. When you start TECFIDERA you might
not notice an improvement, but TECFIDERA may still be working to help prevent your
MS from becoming worse.
The cause of MS is not yet known, MS affects the brain and spinal cord. In MS, the
body's immune system reacts against its own myelin (the 'insulation' surrounding nerve
fibres). In relapsing forms of MS, people have 'exacerbations' from time to time (e.g.
blurred vision, weakness in the legs or arms, or loss of control of bowel or bladder
function). They are followed by periods of recovery. Recovery may be complete or incomplete.
If it is incomplete there is 'progression of disability'.
TECFIDERA contains the active ingredient dimethyl fumarate. Dimethyl fumarate decreases
the inflammation in your brain that is caused by MS and thereby reduces nerve damage.
TECFIDERA works by reducing inflammatory responses in cells and helps to protect the
central nervous system cells against attack. Inflammation of the brain is an important
part of the MS disease process.
Ask your doctor if you have any questions about why this medicine has been prescribed
for you.
Your doctor may have prescribed it for another reason.
TECFIDERA has not been studied in patients with chronic progressive MS.
Safety and effectiveness in children younger than 18 years have not been established.
This medicine is not addictive.
This medicine is available only with a doctor's prescription.
read more
|